A recent study from Taiwan revealed a concerning link between newly detected diabetes mellitus and a higher prevalence of ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks and strokes in survivors.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Discover how regular exercise can strengthen your heart, regulate blood sugar and lower heart disease risk for those with ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...

On this Sexual and Reproductive Health Awareness Day learn how certain diseases impact sexual and reproductive health their ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, ...